Search Results
| Year | ID | Type | Category | Title | Authors |
|---|
| 2019 | PSF04 | Poster | Psychosocial Factors |
Characterization of Patients with and without Medically Unexplained Symptoms and High “Yes” Responses on the Review of Systems |
Benjamin A Jones, MD1, William A Kilgo, MD2 and John R Rinker, MD1, (1)Neurology, University of Alabama at Birmingham, Birmingham, AL, (2)Neurology, University of South Alabama, Mobile, AL |
| 2019 | PSF05 | Poster | Psychosocial Factors |
Cognitive Control and Neural Correlates of Emotion Regulation in Multiple Sclerosis |
Elizabeth Herring, B.A., Stephanie Fountain-Zaragoza, M.A., Bryce Boron, B.S. and Ruchika S. Prakash, Ph.D., Department of Psychology, The Ohio State University, Columbus, OH |
| 2019 | PSF06 | Poster | Psychosocial Factors |
Performance Validity Testing in MS |
Rachel Galioto, PhD, Mellen Center, Cleveland Clinic, Cleveland, OH |
| 2019 | PSF07 | Poster | Psychosocial Factors |
Symptoms of Anxiety and Depression Among a Sample of Puerto Rican MS Patients |
| 2019 | PSF08 | Poster | Psychosocial Factors |
Socioeconomic Status, More so Than Race, Is Associated with Self-Reported Levels of Fatigue, Anxiety and Depression in Multiple Sclerosis |
Yujie Wang, MD, Fan Tian, MSE, Peter A Calabresi, MD and Ellen M Mowry, MD, MCR, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD |
| 2019 | PSF09 | Poster | Psychosocial Factors |
Flourishing in Persons with Relapsing-Remitting Multiple Sclerosis: The Role of Affect, Resilience, and Valued Activities |
Jennifer K. Altman, Ph.D.1, Dawn Ehde, PhD2, Kevin N Alschuler, PhD3 and Mark Jensen, Ph.D.1, (1)Rehabilitation Medicine, University of Washington, Seattle, WA, (2)Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA, (3)Neurology, University of Washington School of Medicine, Seattle, WA |
| 2019 | QOL01 | Poster | Quality of Life and Outcomes |
Associations of Pain-Related Illness Intrusiveness and Activity Engagement Among Persons with Multiple Sclerosis |
Elizabeth S Gromisch, PhD1,2,3, Robert D Kerns, Ph.D.4,5,6,7 and John Beauvais, Ph.D.2,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Psychology Service, VA Connecticut Healthcare System, West Haven, CT, (3)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (4)Department of Psychiatry, Yale University School of Medicine, New Haven, CT, (5)Pain Research, Informatics, Multimorbidities and Education (PRIME) Center, VA Connecticut Healthcare System, West Haven, CT, (6)Department of Psychology, Yale University, New Haven, CT, (7)Department of Neurology, Yale University School of Medicine, New Haven, CT |
| 2019 | QOL02 | Poster | Quality of Life and Outcomes |
Computer Assisted Rehabilitation Environment (CAREN) System Utilization Impact on Mood and Quality of Life in Patients with Multiple Sclerosis |
Alexa Kane, PsyD and Amy Sullivan, Psy.D., The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH |
| 2019 | QOL03 | Poster | Quality of Life and Outcomes |
Effects of Weekly Participation in a Wellness Program on Self-Reported Measures for People Living with Multiple Sclerosis: A Two-Year Analysis. |
Tiffany Malone, MSW, MSCS and Brian Hutchinson, PT, MSCS, Multiple Sclerosis Achievement Center, Dignity Health, Citrus Heights, CA |
| 2019 | QOL04 | Poster | Quality of Life and Outcomes |
Sociodemographic and Clinical Correlates of Device-Measured Sedentary Behavior in Multiple Sclerosis |
| 2019 | QOL05 | Poster | Quality of Life and Outcomes |
Alemtuzumab Improves Quality of Life in RRMS Patients Who Developed Thyroid Adverse Events: 6-Year Follow-up |
| 2019 | QOL06 | Poster | Quality of Life and Outcomes |
Impact of Alemtuzumab on Work Capacity in Patients With RRMS: Pooled Analysis of CARE-MS Core Studies |
| 2019 | QOL07 | Poster | Quality of Life and Outcomes |
The Influence of Resiliency on Illness Intrusiveness in Males with Multiple Sclerosis |
Lindsay Neto, MPH1, Elizabeth S Gromisch, PhD1,2, Jessica H Sloan, PhD3, Tuula Tyry, PhD4 and Frederick W. Foley, Ph.D.5,6, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, (4)Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, (5)MS Center, Holy Name Medical Center, Teaneck, NJ, (6)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY |
| 2019 | QOL08 | Poster | Quality of Life and Outcomes |
The Effects of Yoga on Quality of Life in MS |
Megan Weigel, DNP, ARNP-C, MSCN, First Coast Integrative Medicine, Ponte Vedra Beach, FL and Ashley Von Esche, BS, CHES, Jacksonville, FL |
| 2019 | QOL09 | Poster | Quality of Life and Outcomes |
Construct Validity and Internal Consistency of Patient-Reported Symptomscreen in Phase IIIb Trials of Ocrelizumab in Relapsing Multiple Sclerosis (ENSEMBLE and CASTING) |
Ilya Kister, MD1,2, Hans-Peter Hartung, MD3, Patrick Vermersch, PhD4, Regine Buffels, MD5, Robert Kuhelj, PhD5, Susanne Clinch, PhD6, Wei Wei, PhD5 and Gary Cutter, PhD7, (1)Multiple Sclerosis Comprehensive Care Center, New York University Langone Medical Center, New York, NY, (2)Multiple Sclerosis Comprehensive Care Center, Barnabas Health Medical Group, Livingston, NJ, (3)Department of Neurology, UKD, Center of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Dusseldorf, Dusseldorf, Germany, (4)University of Lille, Lille, France, (5)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (6)F. Hoffmann-La Roche Ltd, Welwyn Garden City, United Kingdom, (7)Department of Biostatistics, UAB School of Public Health, Birmingham, AL |
| 2019 | QOL10 | Poster | Quality of Life and Outcomes |
Floodlight Open – a Global, Prospective, Open-Access Study to Better Understand Multiple Sclerosis Using Smartphone Technology |
Johan van Beek, PhD1, Rita Freitas, PharmD, MSc1, Corrado Bernasconi, MD, PhD1, Xavier Montalban, MD, PhD2,3, Helmut Butzkueven, MBBS, PhD4, Ludwig Kappos, MD, PhD5, Jiwon Oh, MD, PhD, FRCPC3, Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath6, Riley Bove, MD, MMSc7, Laura Julian, PhD8, Mike Baker, BSc, MSc1 and Michael Lindemann, MD, PhD1, (1)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (2)Vall d’Hebron University Hospital, Barcelona, Spain, (3)Division of Neurology, University of Toronto, Toronto, ON, Canada, (4)Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia, (5)University Hospital Basel, University of Basel, Basel, Switzerland, (6)Queen Mary University of London, London, United Kingdom, (7)Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, (8)Genentech, Inc., South San Francisco, CA |
| 2019 | QOL11 | Poster | Quality of Life and Outcomes |
Flywheelms – a Novel Patient-Centered Approach to Collect and Integrate Real-World Clinical, Imaging and Digital Outcome Data in Patients with Multiple Sclerosis in the US |
Katherine Belendiuk, PhD1, David Wormser, MSc, MPhil PhD2, Laura Julian, PhD1, Michael Martinec, PhD2, Kieran Mace, PhD1, Mike Baker, BSc, MSc2, Gillian Hanson, ND3, Yucheng Pan, BA3, Troy Astorino, PhD3 and Noga Leviner, PhD3, (1)Genentech, Inc., South San Francisco, CA, (2)F. Hoffmann-La Roche Ltd, Basel, Switzerland, (3)PicnicHealth, San Francisco, CA |
| 2019 | QOL12 | Poster | Quality of Life and Outcomes |
Changes in Clinically-Significant Pain, Fatigue, Depression, and Anxiety in the First 12 Months Following Multiple Sclerosis Diagnosis |
Anna L Kratz, PhD, University of Michigan, Ann Arbor, MI, Dawn Ehde, PhD, Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, WA and Kevin N Alschuler, PhD, Neurology, University of Washington School of Medicine, Seattle, WA |
| 2019 | QOL13 | Poster | Quality of Life and Outcomes |
Functional Gastrointestinal Disorders Negatively Affect Health-Related Quality of Life in Multiple Sclerosis |
Ruth Ann Marrie, MD, PhD, FRCPC, Department of Medicine, University of Manitoba, Winnipeg, MB, Canada, Stella Leung, MSc, Universityof Manitoba, Winnipeg, MB, Canada, Tuula Tyry, PhD, Dignity Health, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, Gary Cutter, PhD, Department of Biostatistics, UAB School of Public Health, Birmingham, AL, Robert J Fox, MD, Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH and Amber Salter, PhD, Biostatistics, Washington University in St Louis, St Louis, MO |
| 2019 | QOL14 | Poster | Quality of Life and Outcomes |
Neurodegenerative Biomarkers in Cognitively Impaired Multiple Sclerosis Patients |
Jacqueline F Rosenthal, MD1,2, Ranliang Hu, MD3, Suzanne Penna, Ph.D.4 and William Tyor, MD1,2, (1)Neurology, Emory University School of Medicine, Atlanta, GA, (2)Neurology, Atlanta Veterans Administration Medical Center, Decatur, GA, (3)Radiology, Emory University School of Medicine, Atlanta, GA, (4)Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA |
| 2019 | QOL15 | Poster | Quality of Life and Outcomes |
Sleep Apnea in Youth with Neuroinflammatory Disorders |
Michelle J Jaeggi, MD1, Stephanie A Grover, MSc, CCRP2, Tara Berenbaum, BSc2, Samantha Stephens, PhD2, Shelly Weiss, MD, FRCPC1,3 and E Ann Yeh, MD1, (1)Division of Neurology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada, (2)Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, (3)Faculty of Medicine, University of Toronto, Toronto, ON, Canada |
| 2019 | QOL16 | Poster | Quality of Life and Outcomes |
Social-Cognitive Correlates of Physical Activity across the Lifespan in Persons with Multiple Sclerosis |
| 2019 | QOL17 | Poster | Quality of Life and Outcomes |
Trait Mindfulness Mediates Depression and Illness Intrusiveness in Multiple Sclerosis: Implications for Treatment |
Jennifer R Miller, MA1, Caroline Altaras, MA2, Vance Zemon, Ph.D.2, Jeffrey G. Portnoy, M.A.3, Shaina Shagalow, B.A.2, Elizabeth S Gromisch, PhD4 and Fred Foley, PhD5, (1)Yeshiva University, New York, NY, (2)Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, (3)Yeshiva University, Ferkauf Graduate School of Psychology, Bronx, NY, (4)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (5)Holy Name Medical Center, Teaneck, NJ |
| 2019 | QOL18 | Poster | Quality of Life and Outcomes |
Provider and Patient Perspectives on the Transition from Pediatric to Adult-Focused MS Care for Patients with Pediatric-Onset Multiple Sclerosis |
Maria C. Bryant, BA1, Cindy Gonzalez, MPH1, Devin S. Mullin, BS1 and Tanuja Chitnis, MD2, (1)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, MA, (2)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA |
| 2019 | QOL19 | Poster | Quality of Life and Outcomes |
A Perspective on the Impact of Multiple Sclerosis in a High-Functioning Individual: A Look Under the Standard Clinical Threshold |
Tim Sabutis, -1, Jamie L Weiss, PhD2, Marina Ziehn, PhD2 and Stephen Krieger, MD3, (1)Omaha, NE, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)Icahn School of Medicine at Mount Sinai, New York City, NY |
| 2019 | QOL20 | Poster | Quality of Life and Outcomes |
Social Support in Multiple Sclerosis: Associations with Quality of Life, Depression, and Fatigue |
Adrianna M Ratajska, BS1, Brian C Healy, PhD1, Tanuja Chitnis, MD2 and Bonnie I Glanz, PhD1, (1)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, MA, (2)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA |
| 2019 | QOL21 | Poster | Quality of Life and Outcomes |
Real World Expierence Managing Injection Site Reactions and Flu-like Symptoms in MS Patients Using Peginterferon beta1-a, 125 Mcg SC (Plefridy) |
Carol Chieffe, RN, BSN, Neurology, Allegheny MS Treatment Center, Pittsburgh, PA |
| 2019 | QOL22 | Poster | Quality of Life and Outcomes |
The Relationship of Sleep Quality to Fatigability and Health Related Quality of Life in Adult Patients with Multiple Sclerosis |
Corey B Lofton, BSN, RN, PhD Student, Dr. Jennifer Frank, PhD and Dr. Karen Heaton, PhD, COHN-S, FNP-BC, FAAN, FAAOHN, School of Nursing, University of Alabama at Birmingham, Birmingham, AL |
| 2019 | QOL23 | Poster | Quality of Life and Outcomes |
Challenges in Transition from Pediatric to Adult-Focused MS Care for Pediatric-Onset MS Patients: Results from a Web-Survey |
Maria C. Bryant, BA1, Cindy Gonzalez, MPH1, Devin S. Mullin, BS1 and Tanuja Chitnis, MD2, (1)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, MA, (2)Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA |
| 2019 | QOL24 | Poster | Quality of Life and Outcomes |
Designing a Practical, Easy-to-Build Electronic Database for the Busy MS Clinic: Barnabas MS Care Center Experience |
Isaac Lipsky, BA, Phoebe Del Boccio, Ms.C, Ph.D, Andrew Sylvester, MD, Matthew Tremblay, MD, Ph.D, Pamela Steele, LPN, Barbara Steel, LPN, Viktoriya Busko, RN, Asia McClain-Wingate, LPN, Mary Yarussi, RN, Ilya Kister, MD, Tia Tilghman, CA and Angela Andrinopoulos, RN, Multiple Sclerosis Comprehensive Care Center, Barnabas Health Medical Group, Livingston, NJ |
| 2019 | QOL25 | Poster | Quality of Life and Outcomes |
Continuous Improvement of MS Care Quality and Outcomes – a Coach Supported Quality Improvement Intervention and Readiness Assessment Approach for the MS Continuous Quality Improvement Collaborative |
Randy Messier, MT, MSA, PCMH CCE, Randy Messier, LLC, Fairfield, VT, Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN, Neurology Associates, PA, Maitland, FL, Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine, Hanover, NH, Caroline Geremakis, PhD, MPH, Medical Evidence, Research and Innovation, Biogen, Waltham, MA and Wanda Castro-Borrero, MD, Biogen, Cambridge, MA |
| 2019 | QOL26 | Poster | Quality of Life and Outcomes |
Proof of Concept: Preliminary Data of a Comprehensive Intervention Aimed at Improving Well-Being and Participation in Multiple Sclerosis (MS) |
Lauren B Strober, Ph.D.1, Michael Di Benedetto, MA2, Alexandra Becker, BS2 and Rachel Cooper, BA2, (1)Neuropsychology & Neuroscience Research, Kessler Foundation, West Orange, NJ, (2)Neuropsychology & and Neuroscience Research, Kessler Foundation, East Hanover, NJ |
| 2019 | QOL27 | Poster | Quality of Life and Outcomes |
The Relationship between Obstructive Sleep Apnea and Age, Gender, EDSS, Disease Duration, and BMI in People with Multiple Sclerosis Who Report Fatigue: More Than Size Matters |
Arianna Cascone, N/A1, Jared Srinivasan, BA1, Annina Giannuzzi, BS1, Karl Wissemann, BA1, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP1, Barbara Bumstead, MS, ANCP, MSCN1, Marijean Buhse, PhD, NP, RN, MSCN1,2, Myassar Zarif, MD1 and Mark Gudesblatt, MD1, (1)South Shore Neurologic Associates, Patchogue, NY, (2)Stony Brook University, Stony Brook, NY |
| 2019 | QOL28 | Poster | Quality of Life and Outcomes |
Clinical Testing for Upper Limb Function in Multiple Sclerosis |
Audrey R Zucker-Levin, PhD, PT, MBA1, Sarah J Donkers, PT, PhD2, Katherine Knox, MD2, Pawan Kumar, MS3, Aman Saini, MD, MPH4 and Michael C Levin, MD5, (1)Physical Therapy, University of Saskatchewan, Saskatoon, SK, Canada, (2)College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada, (3)College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada, (4)Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan College of Medicine, Saskatoon, SK, Canada, (5)Neurology, University of Saskatchewan, Saskatoon, SK, Canada |
| 2019 | QOL29 | Poster | Quality of Life and Outcomes |
Periodic Limb Movements in People with Multiple Sclerosis Who Report Fatigue: Polysomnography Study in a Large Cohort |
Jared Srinivasan, BA, Annina Giannuzzi, BS, Arianna Cascone, N/A, Karl Wissemann, BA, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP, Barbara Bumstead, MS, ANCP, MSCN, Marijean Buhse, PhD, NP, RN, MSCN and Mark Gudesblatt, MD, South Shore Neurologic Associates, Patchogue, NY |
| 2019 | QOL30 | Poster | Quality of Life and Outcomes |
Screening for Cognitive Impairment in People with Multiple Sclerosis: Is a Unidimensional Measure Really Sufficient to Detect the Cognitive Elephant in the Room? |
Mark Gudesblatt, MD1, Jared Srinivasan, BA1, Daniel Golan, MD2, Cynthia Sullivan, PhD3, Jeffrey Wilken, PhD4 and Glen Doniger, PhD5, (1)South Shore Neurologic Associates, Patchogue, NY, (2)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (3)Nursing, State University of New York @ Stony Brook, Stony Brook, NY, (4)Washington Neuropsychology Research Group, Washington, DC, (5)NeuroTrax Corporation, Modiin, Israel |
| 2019 | QOL31 | Poster | Quality of Life and Outcomes |
An Investigation into the Relationship between Patient Perceived Visual Function and Objective Measures of Disease Impact in People with Multiple Sclerosis: Macular Volume, Retinal Nerve Fiber Layer Density, and Visual Evoked Potential Latency |
Ryan Julius, BS, Jared Srinivasan, BA, Annina Giannuzzi, BS, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP and Mark Gudesblatt, MD, South Shore Neurologic Associates, Patchogue, NY |
| 2019 | QOL32 | Poster | Quality of Life and Outcomes |
Multiple Sclerosis and EDSS: A Closer Inspection of the Walking Scale Finds Erratic Walking |
Jared Srinivasan, BA1, Annina Giannuzzi, BS1, Carly Skudin, N/A2, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP1, Marijean Buhse, PhD, NP, RN, MSCN1, Myassar Zarif, MD1 and Mark Gudesblatt, MD1, (1)South Shore Neurologic Associates, Patchogue, NY, (2)Colgate University, Hamilton, NY |
| 2019 | QOL33 | Poster | Quality of Life and Outcomes |
Validity and Potential Added Value of Multi-Domain Computerized Cognitive Assessment for Patients with Multiple Sclerosis |
Daniel Golan, MD1, Jeffrey Wilken, PhD2, Robert L Kane, PhD, ABPP-CN3, Jared Srinivasan, BA4, Myassar Zarif, MD4, Barbara Bumstead, MS, ANCP, MSCN4, Lori Fafard, RN, BSN, CNRN, MSCN, CCRP4, Marijean Buhse, PhD, NP, RN, MSCN4 and Mark Gudesblatt, MD4, (1)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (2)Washington Neuropsychology Research Group, Washington, DC, (3)University of Maryland School of Medicine, Baltimore, MD, (4)South Shore Neurologic Associates, Patchogue, NY |
| 2019 | QOL34 | Poster | Quality of Life and Outcomes |
Comparison of Symptoms, Abilities and Quality of Life of People with MS Provided By Two Distinct Patient-Reported Outcomes Survey Instruments |
Robert N. McBurney, PhD, Sara Loud, MSEE, MBA, Hollie Schmidt, MS and Laura Kolaczkowski, BA, Accelerated Cure Project for MS, Waltham, MA |